Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kerr

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
The New Zealand Medical Journal|July 24, 2025
Response to: "Measuring low-density lipoprotein cholesterol"Andrew Kerr
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 10, 2009
The inside-out endograft: a proposed method to decrease the profile of aortic stent-graftsAndrew Kerr
PDA Journal of Pharmaceutical Science and Technology|April 20, 2011
Adventitious Viruses Detected in Biopharmaceutical Bulk Harvest Samples over a 10 Year PeriodAndrew Kerr, Raymond Nims
The New Zealand Medical Journal|December 6, 2006
The Bold Promise Project: a system change in primary care to support cardiovascular risk screeningGary Sinclair, Andrew Kerr
The New Zealand Medical Journal|April 16, 2014
Infective endocarditis: trends in the disease and how we study themAndrew Kerr, Michael Williams
Applied Ergonomics|May 20, 2009
Frequency of the sit to stand task: An observational study of free-living adultsPhilippa M Dall, Andrew Kerr
The New Zealand Medical Journal|November 15, 2003
Secondary prevention in coronary artery disease patients in South Auckland: moving targets and the current treatment gapSeifeddin El-Jack, Andrew Kerr
The New Zealand Medical Journal|September 30, 2020
Transparency in the year of COVID-19 means tracking and publishing performance in the whole health system: progress on the public reporting of acute coronary syndrome data in New ZealandAndrew Kerr, Carl Shuker, Gerry Devlin
BMJ (Clinical Research Ed.)|January 4, 2011
Is estimating lifetime cardiovascular risk useful?Rod Jackson, Andrew Kerr, Sue Wells
European Heart Journal|July 21, 2016
'Should we reconsider the role of age in treatment allocation for primary prevention of cardiovascular disease?' No, but we can improve risk communication metricsRod Jackson, Andrew Kerr, Sue Wells
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
The New Zealand Medical Journal|July 24, 2025
Response to: "Measuring low-density lipoprotein cholesterol"Andrew Kerr
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 10, 2009
The inside-out endograft: a proposed method to decrease the profile of aortic stent-graftsAndrew Kerr
PDA Journal of Pharmaceutical Science and Technology|April 20, 2011
Adventitious Viruses Detected in Biopharmaceutical Bulk Harvest Samples over a 10 Year PeriodAndrew Kerr, Raymond Nims
The New Zealand Medical Journal|December 6, 2006
The Bold Promise Project: a system change in primary care to support cardiovascular risk screeningGary Sinclair, Andrew Kerr
The New Zealand Medical Journal|April 16, 2014
Infective endocarditis: trends in the disease and how we study themAndrew Kerr, Michael Williams
Applied Ergonomics|May 20, 2009
Frequency of the sit to stand task: An observational study of free-living adultsPhilippa M Dall, Andrew Kerr
The New Zealand Medical Journal|November 15, 2003
Secondary prevention in coronary artery disease patients in South Auckland: moving targets and the current treatment gapSeifeddin El-Jack, Andrew Kerr
The New Zealand Medical Journal|September 30, 2020
Transparency in the year of COVID-19 means tracking and publishing performance in the whole health system: progress on the public reporting of acute coronary syndrome data in New ZealandAndrew Kerr, Carl Shuker, Gerry Devlin
BMJ (Clinical Research Ed.)|January 4, 2011
Is estimating lifetime cardiovascular risk useful?Rod Jackson, Andrew Kerr, Sue Wells
European Heart Journal|July 21, 2016
'Should we reconsider the role of age in treatment allocation for primary prevention of cardiovascular disease?' No, but we can improve risk communication metricsRod Jackson, Andrew Kerr, Sue Wells
Pageof 14